HTEC241220P26000
- 0.00
- 0.000.00%
Robo Global Healthcare Technology And Innovation Etf Newsroom
(BSX) - Analyzing Boston Scientific's Short Interest
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
The hidden winner in the USA election? Cathie Wood's ARKK hit a new high for the year, all thanks to these heavily weighted stocks!
The strong rise of ARKK is mainly attributed to the increase in its heavy holdings, Tesla, and cryptos-related companies, Coinbase and Robinhood.
Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Looking Into Natera's Recent Short Interest
Cracking The Code: Understanding Analyst Reviews For Stryker
This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Stryker Analyst Ratings
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Trending Stocks This Week as Holiday Season Begins With Thanksgiving Break
10 Health Care Stocks With Whale Alerts In Today's Session
(PEN) - Analyzing Penumbra's Short Interest
Bernstein Maintains Market Perform on Arrowhead Pharma, Lowers Price Target to $24
Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
Natera Announces Its Prospera Lung Test Has Met Coverage Requirements From The Centers For Medicare & Medicaid Services' Molecular Diagnostics Services Program For Single Lung Transplant Recipients; This Coverage Applies To SLT Patients In The...
Arrowhead Pharmaceuticals Shares Are Trading Higher. Chardan Capital Maintained a Buy Rating on the Stock.
Chardan Capital Maintains Buy on Arrowhead Pharma, Maintains $60 Price Target
Arrowhead Pharma Analyst Ratings